The US Food and Drug Administration (FDA) has approved a rapid acting inhaled insulin for use at mealtimes by adults with diabetes mellitus. The product, which will be marketed as Afrezza (insulin human) Inhalation Powder, must be used in combination with long acting insulin in people with type 1 diabetes, the FDA warned. Fitness professionals… Read More